These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
217 related articles for article (PubMed ID: 35443818)
1. MicroRNAs as potential biomarkers for the diagnosis of inflammatory bowel disease: a systematic review and meta-analysis. Sun L; Han Y; Wang H; Liu H; Liu S; Yang H; Ren X; Fang Y J Int Med Res; 2022 Apr; 50(4):3000605221089503. PubMed ID: 35443818 [TBL] [Abstract][Full Text] [Related]
2. Long noncoding RNAs and circular RNAs as potential diagnostic biomarkers of inflammatory bowel diseases: a systematic review and meta-analysis. Belete MA; Tadesse S; Tilahun M; Gedefie A; Shibabaw A; Mulatie Z; Wudu MA; Gebremichael S; Debash H; Alebachew M; Alemayehu E Front Immunol; 2024; 15():1362437. PubMed ID: 38524131 [TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of fecal lactoferrin for inflammatory bowel disease: a meta-analysis. Wang Y; Pei F; Wang X; Sun Z; Hu C; Dou H Int J Clin Exp Pathol; 2015; 8(10):12319-32. PubMed ID: 26722419 [TBL] [Abstract][Full Text] [Related]
4. The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Krishnamoorthy A; Chandrapalan S; Ahmed M; Arasaradnam RP J Crohns Colitis; 2024 Feb; 18(2):320-330. PubMed ID: 37540200 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA signatures differentiate Crohn's disease from ulcerative colitis. Schaefer JS; Attumi T; Opekun AR; Abraham B; Hou J; Shelby H; Graham DY; Streckfus C; Klein JR BMC Immunol; 2015 Feb; 16():5. PubMed ID: 25886994 [TBL] [Abstract][Full Text] [Related]
7. Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis. Dai C; Jiang M; Sun MJ; Cao Q J Clin Gastroenterol; 2020 Jul; 54(6):545-553. PubMed ID: 30994521 [TBL] [Abstract][Full Text] [Related]
9. MicroRNAs as Innovative Biomarkers for Inflammatory Bowel Disease and Prediction of Colorectal Cancer. Masi L; Capobianco I; Magrì C; Marafini I; Petito V; Scaldaferri F Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887337 [TBL] [Abstract][Full Text] [Related]
10. Differentially Expressed miRNAs in Ulcerative Colitis and Crohn's Disease. Yarani R; Shojaeian A; Palasca O; Doncheva NT; Jensen LJ; Gorodkin J; Pociot F Front Immunol; 2022; 13():865777. PubMed ID: 35734163 [TBL] [Abstract][Full Text] [Related]
11. microRNA in inflammatory bowel disease at a glance. Alamdari-Palangi V; Vahedi F; Shabaninejad Z; Dokeneheifard S; Movehedpour A; Taheri-Anganeh M; Savardashtaki A Eur J Gastroenterol Hepatol; 2021 Feb; 32(2):140-148. PubMed ID: 32558695 [TBL] [Abstract][Full Text] [Related]
12. MicroRNAs expression influence in ulcerative colitis and Crohn's disease: A pilot study for the identification of diagnostic biomarkers. Quaglio AEV; Santaella FJ; Rodrigues MAM; Sassaki LY; Di Stasi LC World J Gastroenterol; 2021 Dec; 27(45):7801-7812. PubMed ID: 34963743 [TBL] [Abstract][Full Text] [Related]
13. Diagnostic and Prognostic Value of miRNAs in Hepatoblastoma: A Systematic Review With Meta-Analysis. Wu B; Zhen K; Guo L; Sun C Technol Cancer Res Treat; 2022; 21():15330338221087830. PubMed ID: 35532186 [No Abstract] [Full Text] [Related]
14. Panels of circulating microRNAs as potential diagnostic biomarkers for breast cancer: a systematic review and meta-analysis. Nguyen THN; Nguyen TTN; Nguyen TTM; Nguyen LHM; Huynh LH; Phan HN; Nguyen HT Breast Cancer Res Treat; 2022 Nov; 196(1):1-15. PubMed ID: 36085533 [TBL] [Abstract][Full Text] [Related]
15. Differential Expression of microRNAs in Peripheral Blood Mononuclear Cells Identifies Autophagy and TGF-Beta-Related Signatures Aberrantly Expressed in Inflammatory Bowel Disease. Mohammadi A; Kelly OB; Filice M; Kabakchiev B; Smith MI; Silverberg MS J Crohns Colitis; 2018 Apr; 12(5):568-581. PubMed ID: 29420705 [TBL] [Abstract][Full Text] [Related]
16. Clinical utility of microRNA-378 as early diagnostic biomarker of human cancers: a meta-analysis of diagnostic test. Li ZZ; Shen LF; Li YY; Chen P; Chen LZ Oncotarget; 2016 Sep; 7(36):58569-58578. PubMed ID: 27448977 [TBL] [Abstract][Full Text] [Related]
17. Novel specific microRNA biomarkers in idiopathic inflammatory bowel disease unrelated to disease activity. Lin J; Welker NC; Zhao Z; Li Y; Zhang J; Reuss SA; Zhang X; Lee H; Liu Y; Bronner MP Mod Pathol; 2014 Apr; 27(4):602-8. PubMed ID: 24051693 [TBL] [Abstract][Full Text] [Related]
18. Serum long noncoding RNA H19/micro RNA-675-5p axis as a probable diagnostic biomarker in inflammatory bowel disease. Shaker OG; Safa A; Khairy A; Abozeid NF Mol Biol Rep; 2023 Nov; 50(11):9029-9036. PubMed ID: 37716920 [TBL] [Abstract][Full Text] [Related]
19. MicroRNAs in inflammatory bowel disease: What do we know and what can we expect? de Oliveira ECS; Quaglio AEV; Grillo TG; Di Stasi LC; Sassaki LY World J Gastroenterol; 2024 Apr; 30(16):2184-2190. PubMed ID: 38690020 [TBL] [Abstract][Full Text] [Related]
20. MicroRNAs as Biomarkers for the Diagnostics of Bladder Cancer: a Meta-Analysis. Chen L; Cui Z; Liu Y; Bai Y; Lan F Clin Lab; 2015; 61(8):1101-8. PubMed ID: 26427157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]